Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
CSF1R-related leukoencephalopathy mimicking primary progressive multiple sclerosis.
Nerve conduction velocity in CMT1A: what else can we tell?
Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study.
B Cell Malignancies Frequently Target the Autoreactive B Cell Repertoire.
Static and dynamic functional connectivity in patients with chronic fatigue syndrome: use of arterial spin labelling fMRI.
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Cerebral vasomotor reactivity in neurodegenerative diseases.
Nogo receptor 1 is expressed in both primary cultured glial cells and neurons.
Multiple sclerosis activated by anti-tumor necrosis factor α (Etanercept) and the genetic risk.
Subcutaneous vs. Intravenous Immunoglobulin for Chronic Autoimmune Neuropathies: A Meta-analysis.
Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
The Inflammatory Role of Platelets: Translational Insights from Experimental Studies of Autoimmune Disorders.
Neonatal Dexamethasone Treatment Exacerbates Hypoxia/Ischemia-Induced White Matter Injury.
Effects of Hindlimb Unweighting on MBP and GDNF Expression and Morphology in Rat Dorsal Root Ganglia Neurons.
Structural Alterations of Segmented Macular Inner Layers in Aquaporin4-Antibody-Positive Optic Neuritis Patients in a Chinese Population.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease.
Exploring the feasibility and acceptability of sensor monitoring of gait and falls in the homes of persons with multiple sclerosis.
White matter correlates of episodic memory encoding and retrieval in schizophrenia.
Pediatric multiple sclerosis: The 2015 Sydney Carter Award Lecture.
Contribution of mast cells to injury mechanisms in a mouse model of pediatric traumatic brain injury.
Nonlinear associations between human values and neuroanatomy.
Pages
« first
‹ previous
…
748
749
750
751
752
753
754
755
756
…
next ›
last »